Pilot Study for Patients With Poor Response to Deferasirox
Conditions
- Transfusion-dependent Hemachromatosis
- Thalassemia Major
- Sickle Cell Disease
Interventions
- DRUG: Deferoxamine
- DRUG: Deferasirox
- RADIATION: HIDA
Sponsor
Boston Children's Hospital
Collaborators